...://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Hyperkalemia is associated with an increased risk of arrhythmias and mortality...

... Journals Publication Model ( https://dbpia.nl.go.kr/journals/pages/open_access/funder_policies/chorus/standard_publication_model ) Abstract Background Bradycardia, Renal failure, AV-Nodal blockers, Shock, Hyperkalemia (BRASH) Syndrome new clinical entities due to a vicious cycle in which hyperkalemia...

...Fandy Hazzy; M Saifur Rohman Abstract Background Bradycardia, Renal failure, AV-Nodal blockers, Shock, Hyperkalemia (BRASH) Syndrome new clinical entities due to a vicious cycle in which hyperkalemia from renal failure synergizes with AV-nodal blockers, consequently between the clinical...

... with mortality and/or VA in patients with AMI using the following MeSH headings/text words: potassium/blood; hypokalemia; hyperkalemia; mortality; arrhythmia, cardiac; tachycardia, ventricular; fibrillation, ventricular. The detailed strategy is shown in Supplementary Tables 1 and 2 . No language restrictions...

...) did not reduce the risk of renal and cardiovascular outcomes compared with the single use of either agent. Dual therapy however increased the incidence of hyperkalemia. We examined risk factors for hyper- and hyokalemia and hypothesized that both would be associated with worse cardiovascular and renal...

... participation of type II muscle fibers. An increase in plasma potassium in response to physical exercise becomes accentuated in patients with HF. ¹⁵ This hyperkalemia hinders the contractile efficiency of type II muscle fibers, ¹⁶ thereby affecting purine metabolism and consequently...

... be accounted for by anoxia-dependent opening of I_K(ATP). Myocardial ischemia Hyperkalemia Acidosis Anoxia Membrane excitability Action potential duration Potassium channel ATP sensitive Computer model Time for primary review 42 days. The major pathophysiological component...

... with both hypo- and hyperkalaemia as well as guidance for the use of potassium-binders. Key-words: potassium heart failure hypokalaemia hyperkalemia dyskalaemia potassium-binder comorbidities dyskalaemia hyperkalaemia hypokalaemia potassium prognostic determinants diuretics EMPHASIS Eplerenone...